Chester County News and Community Website
MALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH) announced significant recent progress in strengthening the company’s business development team to support its strategic objective of expanding and diversifying its customer …
Read More
BERWYN, PA — AscellaHealth, a national specialty pharmacy benefit manager (SPBM) serving commercial, Medicare and Medicaid segments, is collaborating with Group & Pension Administrators (GPA), the largest independently owned third-party …
Read More
MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, this week reported financial results for …
Read More
BERWYN, PA — Amring Pharmaceuticals Inc. (Amring), a niche brand and generic pharmaceutical company, announced an agreement with Amzell B.V. (Amzell) that will further strengthen its position in the marketplace …
Read More
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX ) recently announced financial results for the fourth quarter and year ended December 31, 2020, and highlighted recent corporate accomplishments.
Read More MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, and BioVectra Inc., an innovative global …
Read More
EXTON, PA — Melior Pharmaceuticals announced that it has received clearance of its Investigational New Drug (IND) application for the clinical development of its novel, first-in-class lyn kinase activator, tolimidone, …
Read More
CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, reported its financial …
Read More
WASHINGTON, D.C. — President Biden announced this week that his Administration has helped forge a historic manufacturing collaboration between two of the largest U.S. health care and pharmaceutical companies, Merck …
Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, recently announced its financial results for the fourth quarter …
Read More